August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Thor Halfdanarson: The risk of recurrence following resection of pNETs
Nov 1, 2024, 12:08

Thor Halfdanarson: The risk of recurrence following resection of pNETs

Thor Halfdanarson, Vice President at the North American Neuroendocrine Tumor Society, shared on X:

“This is going to be a favorite paper in the clinic when counseling patients on risk of recurrence following resection of pNETs. Node negativity and absence of lymphovascular invasion predict a very favorable outcome and low recurrence risk.”

Thor Halfdanarson

Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group

Authors: Kota Sahara, Diamantis I. Tsilimigras, Yuki Homma, Jun Kawashima, Shishir K. Maithel, Flavio Rocha, Sharon Weber, Ryan Fields, Kamran Idrees, George A. Poultsides, Cliff Cho, Itaru Endo, Timothy M. Pawlik

Thor Halfdanarson

More posts featuring Thor Halfdanarson.